The Food and Drug Administration recently authorized Novavax’s updated protein-based Covid vaccine for emergency use in individuals aged 12 and older. This move is significant as it opens up a new player in the market, allowing Novavax’s vaccine to compete with established vaccines from Pfizer and Moderna. Novavax’s vaccine specifically targets the omicron subvariant JN.1,
The Basel Committee on Banking Supervision (BCBS) has recently expressed its concerns regarding permissionless blockchains in the financial sector. While these blockchains are public and accessible to anyone, the committee is worried about the risks associated with their permissionless nature. Permissionless blockchains, also known as trustless or public blockchains, are decentralized networks that allow anyone